Screener / SEC EDGAR /CIK 0001295947 /10-K filed May 14, 2026, compared with May 9, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Prestige Consumer Healthcare Inc. PBH

Compare with peers Embed
What it said it expected, against what it reported

4 targets with a reported result

Releases of the last 3 years
Above the range 1 above the last range given
Within the range 0 of 4 range targets
Below the range 3 below the last range given

The numbers PBH said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
Diluted EPS (company-defined)
Fiscal 2027
Given $4.55 to $4.65 release Aug 6, 2026
Lowered $4.48 to $4.55 release Nov 5, 2026
– No standard number
The company's words
Raising fiscal 2027 outlook to include acquisitions; anticipate revenue of $1,290 to $1,315 million and Adjusted Diluted EPS outlook to $4.55 to $4.65 release Aug 6, 2026
Updated Fiscal 2027 Outlook … Ron Lombardi, Chief Executive Officer, stated, "We are updating our fiscal 2027 outlook for revenues to $1,280 million to $1,290 million and adjusted diluted EPS of $4.48 to $4.55 primarily to reflect recent variability in Clear Eyes® production at Pillar5, which is expected to reduce product availability and revenue in the second half. release Nov 5, 2026
Revenue
Fiscal 2027
Given $1.10B to $1.12B release May 13, 2026
Raised $1.29B to $1.31B release Aug 6, 2026
Lowered $1.28B to $1.29B release Nov 5, 2026
– Not reported yet
The company's words
Fiscal 2027 Outlook … Revenue $1,100 million to $1,121 million release May 13, 2026
Raising fiscal 2027 outlook to include acquisitions; anticipate revenue of $1,290 to $1,315 million and Adjusted Diluted EPS outlook to $4.55 to $4.65 release Aug 6, 2026
Ron Lombardi, Chief Executive Officer, stated, "We are updating our fiscal 2027 outlook for revenues to $1,280 million to $1,290 million and adjusted diluted EPS of $4.48 to $4.55 primarily to reflect recent variability in Clear Eyes® production at Pillar5, which is expected to reduce product availability and revenue in the second half. release Nov 5, 2026
Diluted EPS (company-defined)
Fiscal 2026 (ended Mar 31, 2026)
Given $4.70 to $4.82 release May 8, 2025
Lowered $4.54 to $4.58 release Nov 6, 2025
– No standard number
The company's words
Initial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively release May 8, 2025
Fiscal 2026 revenue outlook unchanged; … Adjusted Diluted EPS outlook updated to $4.54 to $4.58, high end of previous range release Nov 6, 2025
Diluted EPS
Fiscal 2026 (ended Mar 31, 2026)
Given $4.50 to $4.58 release Aug 7, 2025
$3.91
10-K filed 2026-05-14
Below the range
The company's words
Revising fiscal 2026 revenue outlook to $1,100 to $1,115 million and Diluted EPS outlook to $4.50 to $4.58 release Aug 7, 2025
Revenue
Fiscal 2026 (ended Mar 31, 2026)
Given $1.14B to $1.16B release May 8, 2025
Lowered $1.10B to $1.11B release Aug 7, 2025
Kept $1.10B to $1.11B release Nov 6, 2025
Lowered $1.10B release Feb 5, 2026
$1.09B
10-K filed 2026-05-14
Below the range
The company's words
Initial Fiscal 2026 Outlook … Revenue $1,140 to $1,155 million release May 8, 2025
Revising fiscal 2026 revenue outlook to $1,100 to $1,115 million and Diluted EPS outlook to $4.50 to $4.58 release Aug 7, 2025
Prior Fiscal 2026 Current Fiscal 2026 Outlook Outlook … Revenue million $1,100 to $1,115 million release Nov 6, 2025
We are narrowing our fiscal 2026 net sales outlook to approximately $1.1 billion to reflect a continued challenging consumer environment while maintaining our outlook for free cash flow of $245 million or higher in fiscal 2026 which reflects our strong and stable financial performance. release Feb 5, 2026
Diluted EPS (company-defined)
Fiscal 2025 (ended Mar 31, 2025)
Given $4.40 to $4.46 release May 14, 2024
– No standard number
The company's words
Initial Full-Year Fiscal 2025 Organic Revenue Growth and EPS Outlook of Approximately 1% and $4.40 to $4.46, respectively release May 14, 2024
Revenue
Fiscal 2025 (ended Mar 31, 2025)
Given $1.12B to $1.14B release May 14, 2024
Kept $1.12B to $1.14B release Aug 8, 2024
Kept $1.12B to $1.14B release Nov 7, 2024
Lowered $1.13B to $1.13B release Feb 6, 2025
$1.14B
10-K filed 2025-05-09
Above the range
The company's words
Fiscal 2025 Outlook … Revenue $1,125 to $1,140 million release May 14, 2024
Fiscal 2025 Outlook … Revenue $1,125 to $1,140 million release Aug 8, 2024
Fiscal 2025 Outlook … Revenue $1,125 to $1,140 million release Nov 7, 2024
Prior Fiscal 2025 Current Fiscal 2025 Outlook Outlook … Revenue million $1,128 to $1,132 million release Feb 6, 2025
Revenue
Fiscal 2024 (ended Mar 31, 2024)
Given $1.14B to $1.14B release Feb 8, 2024
$1.13B
10-K filed 2024-05-15
Below the range
The company's words
Commentary and Updated Outlook for Fiscal 2024 … We continue to anticipate revenues of $1,135 to $1,140 million, thanks to our diverse portfolio of brands. release Feb 8, 2024

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-08), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PBH/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.